A Metabolic-Epigenetic Switch Governs Heart Regeneration Following Succinate Dehydrogenase Inhibition

Cardiac regeneration remains limited in the adult mammalian heart, due to restricted cardiomyocyte proliferative capacity and persistent fibrotic remodeling following injury. We previously demonstrated that malonate, a competitive inhibitor of succinate dehydrogenase (SDH), promotes cardiomyocyte proliferation and functional regeneration after myocardial infarction (MI). Here, we define the mechanisms underlying this regenerative response using integrated single-nucleus RNA-seq and ATAC-seq, revealing widespread transcriptional and epigenetic reprogramming that drives adult cardiomyocyte proliferation and suppresses profibrotic gene expression in the injured heart. To dissect the cell-specific roles of SDH inhibition, we generated conditional deletions of the SDH subunit gene Sdhb in cardiomyocytes and myofibroblasts. Cardiomyocyte-specific Sdhb deletion enhanced cardiomyocyte proliferation both at baseline and post-MI; however, this sustained proliferative response occurred at the expense of restored cardiac function. In contrast, myofibroblast-specific Sdhb deletion suppressed myofibroblast activation and fibrotic remodeling, resulting in improved cardiac function following MI. Mechanistically, SDH inhibition promoted reductive mitochondrial metabolism in cardiomyocytes and triggered epigenetic remodeling marked by reduced H3K4me3 and H3K27me3, establishing a metabolic-epigenetic switch that activates a multicellular cardiac regeneration program in the adult heart. Together, these findings identify SDH as a central regulator of cardiac regeneration through distinct cell-specific and epigenetic mechanisms, and establish metabolic targeting of SDH as a promising strategy for heart regeneration.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-18
DOI
https://doi.org/10.5281/zenodo.15686303
Primary Topic
Congenital heart defects research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Metabolic-Epigenetic Switch Governs Heart Regeneration Following Succinate Dehydrogenase Inhibition

Zenodo (CERN European Organization for Nuclear Research)
Congenital heart defects research
article

A Metabolic-Epigenetic Switch Governs Heart Regeneration Following Succinate Dehydrogenase Inhibition

article en

Abstract

Cardiac regeneration remains limited in the adult mammalian heart, due to restricted cardiomyocyte proliferative capacity and persistent fibrotic remodeling following injury. We previously demonstrated that malonate, a competitive inhibitor of succinate dehydrogenase (SDH), promotes cardiomyocyte proliferation and functional regeneration after myocardial infarction (MI). Here, we define the mechanisms underlying this regenerative response using integrated single-nucleus RNA-seq and ATAC-seq, revealing widespread transcriptional and epigenetic reprogramming that drives adult cardiomyocyte proliferation and suppresses profibrotic gene expression in the injured heart. To dissect the cell-specific roles of SDH inhibition, we generated conditional deletions of the SDH subunit gene Sdhb in cardiomyocytes and myofibroblasts. Cardiomyocyte-specific Sdhb deletion enhanced cardiomyocyte proliferation both at baseline and post-MI; however, this sustained proliferative response occurred at the expense of restored cardiac function. In contrast, myofibroblast-specific Sdhb deletion suppressed myofibroblast activation and fibrotic remodeling, resulting in improved cardiac function following MI. Mechanistically, SDH inhibition promoted reductive mitochondrial metabolism in cardiomyocytes and triggered epigenetic remodeling marked by reduced H3K4me3 and H3K27me3, establishing a metabolic-epigenetic switch that activates a multicellular cardiac regeneration program in the adult heart. Together, these findings identify SDH as a central regulator of cardiac regeneration through distinct cell-specific and epigenetic mechanisms, and establish metabolic targeting of SDH as a promising strategy for heart regeneration.

Zenodo (CERN European Organization for Nuclear Research)
University of Wisconsin–Madison (US), Sanford Burnham Prebys Medical Discovery Institute (US), Discovery Institute (US), Oklahoma State University Oklahoma City (US), University of Pennsylvania (US)
Good health and well-being
Openalex Percentile: Top 61%
Congenital heart defects research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Metabolic-Epigenetic Switch Governs Heart Regeneration Following Succinate Dehydrogenase Inhibition · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS